Literature DB >> 7276164

Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris.

G M Palmieri, D F Nutting, S K Bhattacharya, T E Bertorini, J C Williams.   

Abstract

Cumulative evidence indicates that there is an increased accumulation of calcium in dystrophic muscle and that this may have a pathophysiological role in the progression of the dystrophic process. The accumulation may be related to a defect of the plasma membrane. Because parathyroid hormone (PTH) stimulates calcium influx into the cytosol, the chronic effects of surgical ablation of the parathyroid glands on muscle Ca, Mg, protein synthesis, and histology, as well as plasma creatine phosphokinase (CPK), Ca, and Mg, were studied in normal and dystrophic (BIO 14.6) hamsters. Thyroparathyroidectomized (TPTX) hamsters receiving replacement doses of l-thyroxine were killed at age 90 d, 55 d after TPTX. In intact dystrophic hamsters, the Ca content in the heart was 20 times higher than in normal animals and was reduced by half in TPTX dystrophic hamsters. Similar results were observed in diaphragm and rectus femoris. No abnormalities in Mg content were observed in intact or TPTX dystrophic hamsters. Ether-extractable fat of the heart and diaphragm was reduced in dystrophic hamsters and was not modified by TPTX. Protein synthesis was enhanced in the diaphragm of dystrophic hamsters but was not changed by TPTX. The concentration of CPK in plasma was elevated in dystrophic hamsters and fell significantly after TPTX. In the latter animals, microscopic examination of the heart showed lesser signs of dystrophy, particularly in the degree of fibrosis. To determine the degree of dystrophy at the age when TPTX was performed, identical analyses were made in 35-d-old hamsters. Definitive histological signs of dystrophy were observed, and although the Ca content in heart, diaphragm, and rectus femoris was elevated, the values were lower than in 90-d-old intact and TPTX dystrophic hamsters. This indicates that chronic TPTX in dystrophic hamsters reduces, but does not arrest, the dystrophic process. In normal hamsters, a 50% reduction in plasma Ca concentration was observed 6 h after TPTX; 55 d after TPTX, however, plasma Ca was within normal limits in both normal and dystrophic hamsters. No parathyroid tissue was observed in serial sections of the trachea and adjacent tissues in TPTX animals. This suggests that in chronically TPTX hamsters fed a standard laboratory diet, plasma Ca can be maintained by mechanisms independent of parathyroid function. THE DATA INDICATE THAT IN DYSTROPHIC HAMSTERS TPTX CAUSES A MARKED REDUCTION IN: (a) muscle Ca accumulation, (b) levels of plasma CPK and, (c) intensity of histological changes in the heart. These changes were independent of the levels of plasma Ca and were not observed in normal hamsters. We conclude that PTH accentuates the dystrophic process, probably by enhancing the already increased Ca flux into muscle (apparently caused by defective sarcolemma). We postulate that normal secretion of PTH may have a deleterious effect in congenital or acquired conditions associated with altered plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7276164      PMCID: PMC370845          DOI: 10.1172/jci110299

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  A calcium-activated neutral protease in normal and dystrophic human muscle.

Authors:  N C Kar; C M Pearson
Journal:  Clin Chim Acta       Date:  1976-12-01       Impact factor: 3.786

2.  Retention of 45Ca in rats and lambs associated with the onset of nutritional muscular dystrophy.

Authors:  K O Godwin; J Edwardly; C N Fuss
Journal:  Aust J Biol Sci       Date:  1975-12

3.  On the mechanism of a calcium-associated defect of oxidative phosphorylation in progessive muscular dystrophy.

Authors:  K Wrogemann; B E Jacobson; M C Blanchaer
Journal:  Arch Biochem Biophys       Date:  1973-11       Impact factor: 4.013

4.  Neuromuscular disease in primary hyperparathyroidism.

Authors:  B M Patten; J P Bilezikian; L E Mallette; A Prince; W K Engel; G D Aurbach
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

Review 5.  Hereditary cardiomyopathy: a new disease model.

Authors:  E Bajusz
Journal:  Am Heart J       Date:  1969-05       Impact factor: 4.749

6.  Dystrophic mouse muscles have leaky cell membranes.

Authors:  V Molak; A Stracher; D Erlij
Journal:  Exp Neurol       Date:  1980-11       Impact factor: 5.330

7.  Regulation of cellular calcium metabolism and calcium transport by calcitonin.

Authors:  A B Borle
Journal:  J Membr Biol       Date:  1975-04-23       Impact factor: 1.843

8.  A Ca2+-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle.

Authors:  W R Dayton; D E Goll; M G Zeece; R M Robson; W J Reville
Journal:  Biochemistry       Date:  1976-05-18       Impact factor: 3.162

9.  Lipid content and fatty acid composition of heart and muscle of the BIO 82.62 cardiomyopathic hamster.

Authors:  H A Barakat; G L Dohm; P Loesche; E B Tapscott; C Smith
Journal:  Lipids       Date:  1976-10       Impact factor: 1.880

10.  Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.

Authors:  A Stracher; E B McGowan; S A Shafiq
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

View more
  13 in total

1.  Parathyroid hormone enhances calcium current in snail neurones--simulation of the effect by phorbol esters.

Authors:  P G Kostyuk; E A Lukyanetz; A S Ter-Markosyan
Journal:  Pflugers Arch       Date:  1992-02       Impact factor: 3.657

Review 2.  Structure and function of the respiratory system of the dystrophic hamster.

Authors:  E H Schlenker; J A Burbach
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.

Authors:  Malay S Gandhi; German Kamalov; Atta U Shahbaz; Syamal K Bhattacharya; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

Review 4.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

Review 5.  Myocardial remodeling in low-renin hypertension: molecular pathways to cellular injury in relative aldosteronism.

Authors:  Syamal K Bhattacharya; Malay S Gandhi; German Kamalov; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

6.  Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease.

Authors:  Henrik Vestergaard; Lars ØStergaard Kristensen
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

7.  Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data.

Authors:  F Längle; C Abela; J Koller-Strametz; M Mittelböck; J Bergler-Klein; T Stefenelli; W Woloszczuk; B Niederle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

8.  Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

Authors:  C Symons; F Fortune; R A Greenbaum; P Dandona
Journal:  Br Heart J       Date:  1985-11

9.  Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism.

Authors:  German Kamalov; Robert A Ahokas; Wenyuan Zhao; Atta U Shahbaz; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-13       Impact factor: 4.733

10.  Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.

Authors:  German Kamalov; Prajwal A Deshmukh; Narina Y Baburyan; Malay S Gandhi; Patti L Johnson; Robert A Ahokas; Syamal K Bhattacharya; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2009-05       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.